UCL Cancer Institute



Selected recent Publications involving the GCLP Facility:

  • Roddie, C. et al. AUTO1, a novel fast off CD19CAR delivers durable remissions and prolonged CAR T cell persistence with low CRS or neurotoxicity in adult ALL. Presented at 2019 AACR Annual Meeting, Atlanta, GA, USA (2019). Available at: https://www.abstractsonline.com/pp8/#!/6812/presentation/9977
  • Rizzo, F. M. et al. Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours. Br. J. Cancer 120, 294–300 (2019).
  • Abbosh, C. et al. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545, 446-451 (2017)
  • Jamal-Hanjani, M. et al. Tracking the Evolution of Non-Small-Cell Lung Cancer. N Engl J Med. 376, 2109-2121 (2017)
  • Forster, M. et al. A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC). Presented at: 2016 ASCO Annual Meeting, Chicago, IL, USA. (2016) (2016). Available at: http://meetinglibrary.asco.org/record/128500/video
  • Mandair, D. et al. A comparison of CellCollector with CellSearch in patients with neuroendocrine tumours. Endocr. Relat. Cancer 23, L29-32 (2016).
  • Lemech, C. R. et al. Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial Cancer. Oncology 91, 48–54 (2016).
  • Childs, A. et al. Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours. Br. J. Cancer 115, 1540–1547 (2016).
  • Khan, M. S. et al. Early Changes in Circulating Tumor Cells Are Associated with Response and Survival Following Treatment of Metastatic Neuroendocrine Neoplasms. Clin Cancer Res. 22, 79-85 (2016)